Rational approaches to treatment duration with immunotherapy for kidney cancer
A recent review of the use of immune checkpoint inhibitors [...]
A recent review of the use of immune checkpoint inhibitors [...]
Current guidelines recommend partial nephrectomy as the preferred treatment option [...]
In this video interview, Brenda Martone discusses the clinical nurse [...]
A study published in the Journal of Vascular and Interventional [...]
A recent study published in Science Direct describes how a [...]
In 2015, the standard treatment for most patients with advanced [...]
Over the past couple of years there have been several [...]
Immune checkpoint inhibitors (ICIs), such as nivolumab and ipilimumab have [...]
In this interview with OncLive, Dr Ulka Vaishampayan from Wayne [...]
In this interview with OncLive, professor Sumanta Kumar Pal from [...]